Literature DB >> 7615373

Effects of sex steroids on cell growth and C-myc oncogene expression in LN-CaP and DU-145 prostatic carcinoma cell lines.

F K Asadi1, R Sharifi.   

Abstract

The prostate gland is dependent on androgens for the maintenance of its normal growth and functional integrity. Initially, growth of the majority of prostate tumours can be manipulated by endocrine therapy. In the present study, we evaluated the effects of sex steroids on the cell growth and expression of the C-myc oncogene in two human prostatic adenocarcinoma cell lines. We found that dihydrotestosterone increases the proliferation rate of prostatic cells, and amplification of C-myc oncogene is hormone-dependent. We also demonstrated a positive correlation between the number of cells positive for C-myc oncogene and oncoprotein in hormone-treated prostate cell lines.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615373     DOI: 10.1007/BF02575223

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  22 in total

1.  Cancer statistics, 1992.

Authors:  C C Boring; T S Squires; T Tong
Journal:  CA Cancer J Clin       Date:  1992 Jan-Feb       Impact factor: 508.702

2.  Experimental oncogene induced prostate cancer.

Authors:  T C Thompson; D Kadmon; T L Timme; V W Merz; S Egawa; T Krebs; P T Scardino; S H Park
Journal:  Cancer Surv       Date:  1991

3.  Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ.

Authors:  T C Thompson; J Southgate; G Kitchener; H Land
Journal:  Cell       Date:  1989-03-24       Impact factor: 41.582

4.  Unusual specificity of the androgen receptor in the human prostate tumor cell line LNCaP: high affinity for progestagenic and estrogenic steroids.

Authors:  J Veldscholte; M M Voorhorst-Ogink; J Bolt-de Vries; H C van Rooij; J Trapman; E Mulder
Journal:  Biochim Biophys Acta       Date:  1990-04-09

5.  The partial dependency of human prostatic growth factor on steroid hormones in stimulating thymidine incorporation into DNA.

Authors:  M T Hierowski; M W McDonald; L Dunn; J W Sullivan
Journal:  J Urol       Date:  1987-10       Impact factor: 7.450

6.  ras gene mutations in human prostate cancer.

Authors:  B S Carter; J I Epstein; W B Isaacs
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

7.  Androgen receptor gene expression in human prostate carcinoma cell lines.

Authors:  W D Tilley; C M Wilson; M Marcelli; M J McPhaul
Journal:  Cancer Res       Date:  1990-09-01       Impact factor: 12.701

8.  Expression of a transfected v-Harvey-ras oncogene in a Dunning rat prostate adenocarcinoma and the development of high metastatic ability.

Authors:  B Treiger; J Isaacs
Journal:  J Urol       Date:  1988-12       Impact factor: 7.450

9.  Activated Ki-ras oncogene in human prostatic adenocarcinoma.

Authors:  D M Peehl; N Wehner; T A Stamey
Journal:  Prostate       Date:  1987       Impact factor: 4.104

10.  Expression of cellular oncogenes in human prostatic carcinoma cell lines.

Authors:  A W Rijnders; J A van der Korput; G J van Steenbrugge; J C Romijn; J Trapman
Journal:  Biochem Biophys Res Commun       Date:  1985-10-30       Impact factor: 3.575

View more
  2 in total

1.  Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells.

Authors:  Claudio Festuccia; Adriano Angelucci; Giovanni Luca Gravina; Paola Muzi; Carlo Vicentini; Mauro Bologna
Journal:  J Cancer Res Clin Oncol       Date:  2005-01-14       Impact factor: 4.553

2.  Myc confers androgen-independent prostate cancer cell growth.

Authors:  David Bernard; Albin Pourtier-Manzanedo; Jesús Gil; David H Beach
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.